FEMS Yeast Res 2:295305 Rioseras B et al (2016) Characterization of SCO4439, a D-alanyl-D-alanine carboxypeptidase involved in spore cell wall maturation, resistance, and germination in Streptomyces coelicolor
Body composition in DIO mice with/without NNMT inhibition showing reduced WAT mass with preserved lean mass relative to diet-matched controls [1,3,4]
The peptides under consideration this week are: BPC-157, proposed for treating ulcerative colitis KPV for wound healing and inflammatory conditions TB-500 for wound healing MOTS-c for obesity and osteoporosis Emideltide for opioid withdrawal, chronic insomnia and narcolepsy Semax for certain neurological disorders Epitalon for insomnia The FDA advisory committee "will be determining whether or not it will allow access to these substances through legitimate state-licensed compounding pharmacies," said Scott Brunner, chief executive officer of the Alliance for Pharmacy Compounding, who sent a public letter to the committee in support of adding peptides to the list
For full insight into our criteria for including and ranking GLP-1 providers, please review our full methodology
